[Immunization against L-asparaginase. Demonstration and characteristics of antibodies. Clinical value].
D000707:Anaphylaxis / Q000209:etiology*; D000906:Antibodies; D000917:Antibody Formation; D000918:Antibody Specificity; D001215:Asparaginase / Q000009:adverse effects* / Q000627:therapeutic use; D003168:Complement Fixation Tests; D004342:Drug Hypersensitivity / Q000209:etiology*; D006207:Half-Life; D006801:Humans; D005779:Immunodiffusion; D007165:Immunosuppression Therapy; D007841:Latex Fixation Tests; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*
D000906:Antibodies; D001215:Asparaginase
L'immunisation contre la L-asparaginase. Mise en évidence et caractéristiques des anticorps. Intérêt clinique.